1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: WCCC-CO-8751, NCI-V87-0225
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: Under 30
Sponsor: NCI
Protocol IDs: COG-AHOD0121, NCT00070187, AHOD0121
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI
Protocol IDs: JHOC-97080106, JHOC-9726, NCI-V98-1453, NCT00003414
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to physiologic 65
Sponsor: NCI
Protocol IDs: CPMC-IRB-7608, CPMC-CAMP-014, NCI-G00-1890, NCT00008203
|
|
5.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: BGSM-89285, NCI-V85-0243
|
|
6.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BGSM-89186, NCI-V86-0108
|
|
7.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-862051, NCCTG-86-20-51
|
|
8.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: SWOG-8642
|
|
9.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-874651, MAYO-874651, MDA-DM-89021, NCCTG-87-46-51
|
|
10.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-18871
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: EORTC-08883
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-ME7, NCI-V88-0609, ME7
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: EORTC-30885
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UPCC-3695, NCI-92-C-0105H, NCI-T91-0238D, T91-0238
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: EORTC-DKG-80-1
|
|
16.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: MSKCC-94134, NCI-V95-0629, NCT00002637
|
|
17.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to physiologic 60
Sponsor: Other
Protocol IDs: CU-CAMP-10, NCI-V96-0873, NCT00002761
|
|
18.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MTS-96322-ME, NCI-T96-0015O, NCT00002796, T96-0015
|
|
19.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7992
|
|
20.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 19 to 74
Sponsor:
Protocol IDs: YALE-3580, YALE-HIC-2114
|
|
21.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor:
Protocol IDs: MDA-DT-8132
|
|
22.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 17 and over
Sponsor: NCI
Protocol IDs: DFCI-85137, NCI-T85-0269W, T85-0269
|
|
23.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under 21
Sponsor: NCI
Protocol IDs: SJCRH-IFN-GAMMA, NCI-T87-0061D, T87-0061
|
|
24.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 17
Sponsor: NCI
Protocol IDs: BRMP-8701, NCI-87-C-82, NCI-T87-0153N, T87-0153
|
|
25.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8735
|
